Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carbonic anhydrase 12 (CA12) is a membrane-associated zinc metalloenzyme that catalyzes the reversible hydration of carbon dioxide to bicarbonate and protons. It plays a crucial role in pH regulation, ion transport, and fluid secretion in various tissues. Overexpression is associated with certain cancers, while loss-of-function mutations can lead to electrolyte imbalances and impaired fluid secretion.
Carbonic anhydrase inhibitors block the active site of the enzyme, preventing the hydration of carbon dioxide and subsequent production of bicarbonate and protons. This can affect pH regulation and ion transport.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carbonic Anhydrase 12 (CA12).